Sanofi
Sanofi is Still Correcting. NASDAQ:SNYForming subsequent ABC Pattern, broke the floor. Fibonacci targets in place. Quite close to the first one by the way. We're going down. Down, down, down. NFA
MRNA- Leader in the vaccine race. Ladder buy to avoid the riskModerna is the first company to start the phase 3 trial in July and could have the supply ready earliest by Oct and accelerated approval earliest by December, according to Nami Sumida/BioPharma Dive and morningstar.
Other competitors are scheduled to have accelerated approval the earliest around early 2021.
Sanofi, leading in the fight for COVID-19Sanofi is leading the clinical development and registration of the COVID-19 vaccine and expects a Phase 1/ 2 study to start in September, followed by a Phase 3 study by the end of 2020. If data are positive, regulatory approval could be achieved by the first half of 2021. In parallel, Sanofi and GSK are scaling up manufacturing of the antigen and adjuvant to produce up to one billion doses per year overall.
Sanofi and GSK are committed to making the vaccine available globally
As we are hitting the golden zone in FIB retrace. Im going to put this on watch.
CLOSE TO PULLBACK UP ZONES SANOFI - SAN - 240MNThe price has been ranging widely, coming back to its pre-pandemic trend.
The price is coming very closely to two different important "pullback up" line.
Probability of nice entry for a long direction trade.
In the flip side, if it breaks down those two lines further, there is a risk to see the price approaching the horizontal black line.
For the moment, the probability stays in the direction of the pitchfork, up trending.
SANOFI is likely to go bullish .NASDAQ:SNY is showing signs that it is heading up to around the 54.5 area .There is a possibility that It could return back to around the 48 area and then bounce back from there to around the 54.5 area but I think price would rather break significantly above the 50 until around the 54-55 area .
Sanofi uptrendSanofi is currently in an uptrend, with a bump and run present, a triple top and a new support formed from the mirror resistance level. A bull flag formation would be indicative of a trendline break.
SNY Bump and RunSNY has experience two bump and runs throughout the course of its listing. Will a third follow? If so will it be immediately or will further trend strengthening occur. The bump and runs also resulted in two triple tops.
SANOFI - POSSIBLE UPSIDESANOFI
CMP 6304
STOP 6000
TARGET OPEN
Daily Chart
Possible Volatility contraction pattern 3T observed.
Price getting support from pivot zones.
Pivot based emas started spreading out indicating possibility of price moving up.
Long SANSanofi after several tries broke its cup & handle formation a successfully retested it. It seems to be also forming a reverse H&S.
Stop: 74.60
Targets: 85.60 / 92.90
SANOFI Is Ready For a ReboundDespite the undeniable bearish momentum, the €63.50 support is a mayor player in Sanofi. It is likely that a rebound towards at least the €68 zone occurs during the next weeks. A second likely bullish target is €71.95.
Good luck fellow traders
Time to go long on PIRS, very long.The has been absolutely no fundamental change to this bio company that has multiple big pharma partners. Yet due to the overall biotech downturn NASDAQ:PIRS was hit pretty hard. This presents a true 10 bagger opportunity , and Im not even remotely stretching the truth. The technicals show you why right now is the PERFECT time to buy. A little due diligence will show you why its a must hold in 2016.
As you will find here --> there is plenty in the pipeline, both propietary and partnered. And when your partners are this strong, its hard to fail.
